Oncaspar

In the US, Oncaspar (pegaspargase systemic) is a member of the drug class miscellaneous antineoplastics and is used to treat Acute Lymphoblastic Leukemia.

US matches:

• Oncaspar

Ingredient matches for Oncaspar

Gadodiamide

Gadodiamide is reported as an ingredient of Oncaspar in the following countries:

• Greece

Pegaspargase

Pegaspargase is reported as an ingredient of Oncaspar in the following countries:

• Argentina


• Germany


• Poland


• United States

International Drug Name Search